Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06297941
Status:
RECRUITING
Last Update Posted:
2024-05-02
First Post:
2024-02-23
Brief Title:
Study of REM-422 in Patients With AML or Higher Risk MDS
Sponsor:
Remix Therapeutics
Organization:
Remix Therapeutics
Organization Data
Organization:
Remix Therapeutics
Class:
INDUSTRY
Study ID:
REM-422-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Remix Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None